LORIE NATOLI: Open Payments
NPI 1215943436 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,681 in 84 payments from 21 companies in 2025. Trend: 2023 $285 · 2024 $1,490 · 2025 $1,681
Food & beverage: $1,681
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $433 |
| Madrigal Pharmaceuticals | 8 | $257 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $209 |
| Aimmune Therapeutics, Inc. | 6 | $118 |
| Phathom Pharmaceuticals, Inc. | 6 | $103 |
| PFIZER INC. | 5 | $91 |
| Organon LLC | 3 | $62 |
| Ipsen Biopharmaceuticals, Inc | 3 | $59 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| Novo Nordisk Inc | 2 | $52 |
Products named: REZDIFFRA, CREON, RINVOQ, ENTYVIO, VOQUEZNA, ZENPEP, DUPIXENT, XELJANZ.
Industry payments across PA — which companies pay providers there.
